Although the role of radiation therapy is well established in this setting, the role of radical prostatectomy in treating men with de novo oligometastatic prostate cancer has not been well defined.

The FDA expanded the approval of Pluvicto (lutetium Lu 177 vipivotide tetraxetan) to include patients with PSMA-positive mCRPC who have been treated with ARPI therapy and are considered appropriate to ...

The FDA has approved Imfinzi® (durvalumab), in combination with gemcitabine and cisplatin, for the treatment of adult patients with MIBC.

More than 2 decades have passed since I became the first full-time editor of Renal & Urology News. During that time, the ...

(HealthDay News) — A wearable T-shirt monitor can help oncological urology patients return home sooner after robotic-assisted surgery, according to a study presented at the 40th annual European ...

(HealthDay News) — Avoidable mortality is increasing in the United States and decreasing in comparator countries, according to a study published online March 24 in JAMA Internal Medicine.

A Chinese woman is the third person in the world living with a gene-edited pig kidney, and nearly 3 weeks after surgery, doctors say she’s doing well. The woman, reportedly 69 years old, had kidney ...

The provision of physician control over aspects of their clinical work environment should be considered to reduce burnout and improve retention. Poor control over specific aspects of work was ...

Pembrolizumab plus docetaxel does not improve radiographic progression-free survival or overall survival compared with docetaxel alone. Adding pembrolizumab to docetaxel is not better than ...

Credit: Thinkstock Investigators reported findings from a 2-sample Mendelian randomization analysis of large cohorts of participants in genome-wide association studies who were predominantly of ...

There is a high unmet need for effective neoadjuvant treatments for muscle-invasive bladder cancer for patients who cannot tolerate or refuse cisplatin chemotherapy.